TipRanks on MSN

JNJ: TECVAYLI/DARZALEX FASPRO regimen shows positive results in study

Johnson & Johnson announced that an investigational immune-based induction regimen with TECVAYLI and DARZALEX FASPRO demonstrated meaningful ...